This inventor holds 2 USPTO granted patents. Top assignee: University of California. Active years: 2012-2014.
Company Filing History:
Years Active: 2012-2014
Title: Innovations by Felix Olasagasti
Introduction
Felix Olasagasti is an accomplished inventor based in Santa Cruz, CA (US). He has made significant contributions to the fields of molecular biology and drug discovery through his innovative patents. With a total of 2 patents, Olasagasti's work focuses on advanced methods and devices that enhance our understanding and manipulation of biological processes.
Latest Patents
Olasagasti's latest patents include "Compositions, devices, systems, for using a nanopore" and "Lipid-assisted synthesis of polymer compounds and methods for their use." The first patent provides devices and methods that can detect and control individual polymers in a mixture, allowing for rapid determination of nucleotide base sequences under feedback control. This invention is particularly useful in drug discovery and molecular biology. The second patent outlines methods for synthesizing polymers from monomers without the need for catalytic enzymes, utilizing fluctuating temperature and hydration conditions to facilitate chemical bond formation. This method also finds applications in molecular biology and computational devices.
Career Highlights
Felix Olasagasti is affiliated with the University of California, where he continues to advance research in molecular biology and related fields. His innovative approaches have garnered attention and recognition within the scientific community.
Collaborations
Olasagasti collaborates with notable colleagues such as Seico Benner and Kate Lieberman, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Felix Olasagasti's contributions to the field of molecular biology through his patents demonstrate his commitment to advancing scientific knowledge and technology. His work not only enhances our understanding of biological processes but also paves the way for future innovations in drug discovery and molecular applications.
